Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report.
Eur J Hosp Pharm
; 29(4): 235-236, 2022 07.
Article
in English
| MEDLINE | ID: covidwho-1197264
ABSTRACT
A patient with severe asthma on benralizumab therapy was admitted to the intensive care unit (ICU) for a coronavirus disease 2019 (COVID-19) infection. At the end of the 8 week benralizumab dosing interval, discussion arose as to whether benralizumab should be administered or if treatment should be discontinued, due to the lack of experience with benralizumab in this situation. Severe broncho-obstruction developed, and the next injection of benralizumab was administered during ICU admission without detrimental symptoms. With this case report, we would like to share our experience with the safe administration of benralizumab during COVID-19 pneumonia, guiding doctors in future decision making.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Asthma
/
Anti-Asthmatic Agents
/
COVID-19 Drug Treatment
Type of study:
Case report
/
Diagnostic study
Limits:
Humans
Language:
English
Journal:
Eur J Hosp Pharm
Year:
2022
Document Type:
Article
Affiliation country:
Ejhpharm-2020-002660
Similar
MEDLINE
...
LILACS
LIS